Skip to main content
logo
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.64
+0.18 (2.79%)
At close: May 28, 2026, 4:00 PM EDT
6.60
-0.04 (-0.60%)
After-hours: May 28, 2026, 6:41 PM EDT

Vanda Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
399521279243420877
Market Cap Growth
68.13%86.63%15.04%-42.14%-52.16%21.66%
Enterprise Value
213.97528.34287.4-138.46-38.41454.33
Last Close Price
6.648.824.794.227.3915.69
PE Ratio
---105.5067.1827.05
Forward PE
----21.7421.94
PS Ratio
1.852.411.411.261.653.26
PB Ratio
1.381.590.520.450.801.74
P/TBV Ratio
1.401.590.520.450.801.77
P/FCF Ratio
---19.5513.4013.78
P/OCF Ratio
---18.9713.1213.66
EV/Sales Ratio
0.982.441.45-0.72-0.151.69
EV/EBITDA Ratio
---14.40-10.09
EV/EBIT Ratio
---9.92-10.78
EV/FCF Ratio
-----7.14
Debt / Equity Ratio
0.030.020.020.010.020.02
Debt / EBITDA Ratio
----0.970.22
Debt / FCF Ratio
---0.560.280.16
Net Debt / Equity Ratio
0.030.020.02-0.70-0.87-0.84
Net Debt / EBITDA Ratio
-0.05-0.05-0.2639.64-50.55-9.39
Net Debt / FCF Ratio
-0.05-0.06-0.50-30.70-14.63-6.64
Asset Turnover
1.110.940.440.300.410.48
Inventory Turnover
0.981.101.021.242.233.00
Quick Ratio
0.420.380.474.825.476.25
Current Ratio
0.510.470.584.945.686.43
Return on Equity (ROE)
-78.80%-50.93%-3.49%0.47%1.22%6.92%
Return on Assets (ROA)
-130.74%-104.54%-7.35%-0.86%0.57%5.85%
Return on Invested Capital (ROIC)
-194.66%-136.39%-15.01%-3.21%2.83%25.31%
Return on Capital Employed (ROCE)
-286.84%-140.80%-11.22%-2.53%1.19%8.54%
Earnings Yield
---0.95%1.49%3.70%
FCF Yield
---5.11%7.46%7.26%
Buyback Yield / Dilution
-1.41%-1.34%-1.03%-1.01%-0.11%-3.14%
Total Shareholder Return
-1.41%-1.34%-1.03%-1.01%-0.11%-3.14%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q